Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection?
Hearse
D J
DJ
Rayne Institute, St. Thomas' Hospital, London, UK.
D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D004285:Dogs; D006801:Humans; D015640:Ion Channel Gating; D009203:Myocardial Infarction / Q000517:prevention & control*; D017202:Myocardial Ischemia / Q000188:drug therapy; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control; D026902:Potassium Channel Blockers; D015221:Potassium Channels / Q000819:agonists / Q000187:drug effects*; D051381:Rats
D002316:Cardiotonic Agents; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D000255:Adenosine Triphosphate